AWM
SYRS

Activest Wealth Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Activest Wealth Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-87
Closed -$20 – 1185
2024
Q4 		$20 Hold
87
– – ﹤0.01% 844
2024
Q3 		$187 Hold
87
– – ﹤0.01% 515
2024
Q2 		$449 Buy
+87
New +$457 ﹤0.01% 463

Other funds holding SYRS

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Activest Wealth Management's SYRS Position: Q1 2025 in Review

Activest Wealth Management sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2025, closing a stake of 87 shares — an estimated $20 sold.

Activest Wealth Management first reported a position in SYRS in Q2 2024 and held it in 3 quarters. The position peaked at $449 in Q2 2024. 7 funds tracked by Wall St. Rank hold SYRS as of Q1 2025.

  • Activest Wealth Management reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Activest Wealth Management sold 87 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2025, an estimated $20.
  • Activest Wealth Management first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q2 2024 and held it in 3 quarters.
  • Activest Wealth Management's Syros Pharmaceuticals, Inc. Common Stock position peaked at $449 in Q2 2024.
  • 7 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2025.

Based on Activest Wealth Management's 13F filing for Q1 2025, filed 15 May 2025.